CD58 could be a leukemic marker in patients with relapsed/refractory B-cell acute lymphoblastic leukemia after multiline therapies
Year: 2025
Type: article
Study design: Observational Study
DOI: 10.1093/ajcp/aqae166
Authors: Xinjian Yu, Pan Li, Heyuan Feng, Jian Kang, Yafeng Li, Shuangyou Liu
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409602718